It also established a subsidiary in Singapore to augment its activities in the South East region and help the marketing of products from the supercritical fluid extraction facility at Dehradun to ...

Metro Line 3 Phase 2 Opens Up Connecting BKC To Worli; Over 26K Commuters Take Ride On Day 1 After Opening For Public Despite the seamless connectivity and the official launch on a weekend ...

Australian-US biotech Opthea Ltd has reported disappointing phase 3 results with its lead drug for vision-robbing disease wet age-related macular degeneration (AMD), throwing its future into doubt ...

The phase 3 VISIONARY trial (NCT05248646) included 530 adults with biopsy-proven IgAN from 240 sites across 31 countries. Median patient age was 42-43 years, and nearly two-thirds were male.

Bagsværd, Denmark, 12 June 2025 – Novo Nordisk today announced that it will advance subcutaneous and oral amycretin into phase 3 development in weight management based on completed clinical ...

Merck stock rises on successful Phase 3 trial results for its cholesterol drug Editor Senad Karaahmetovic Stock Markets Published 06/09/2025, 07:07 AM ...

Government Bans SNAP Recipients From Buying Soda And Candy In 3 States Jonas Brothers Cancel Six Stadium Concerts, Including Dodger Stadium; Arena or Amphitheater Gigs Step In as Replacements ...

Phase 1 and interim phase 2 data met GSK’s immunogenicity success criteria, the London-based drugmaker said. Yet, GSK has decided to hand off to India’s Bharat for the phase 3 trial.

In June 2025, Bristol-Myers Squibb (NYSE:BMY) announced positive results from the Phase 3 POETYK PsA-1 trial of Sotyktu, showcasing its efficacy in treating psoriatic arthritis. This significant ...

JERUSALEM — Israel and Germany have started preparations to deliver the the Arrow-3 missile shield to German forces in the coming months, the Israeli Ministry of Defense announced. According to ...

Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.

ACHIEVE-1 is a phase 3 trial, which evaluated the safety and efficacy of orforglipron compared to placebo in adults with type 2 diabetes and inadequate glycemic control with diet and exercise alone.